维普期刊资源整合服务平台（V6.5）

23篇 您的检索式：作者名="Eder IE"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Targeting the andro-gen receptor in hormone refractory prostate cancer-newconcepts显示文摘	Eder IE Haag P Bartsch G	2005	Future Oncol2005，1，1：	1
2	Inhibition ofLNCaP prostate tumor growth in vivo by an antisenseoligonuceotide directed against the human androgen re-ceptor显示文摘	Eder IE Hoffmann J Rogatsch H	2002	Cancer Gene Ther2002，9，2：	1
3	Novel therapeutic approaches for the treatment of castration-resistant prostate cancer显示文摘	HEIDEGGER I MASSONER P EDER IE	2013	J Steroid Biochem Mol Biol2013，138，：	1
4	Long-term androgen-ablation causes increased resistance to PI3K/Akt pathway inhibition in proslate cancer ceUs显示文摘	PFEIL K EDER IE PUTZ T	2004	Prostate2004，58，：	1
5	Overexpression of the antiapop- totic protein MCL-1 is an early event in prostate cancer显示文摘	Pfeil K Eder IE Bektic J	2004	Euro- pean Urology Supplements2004，3，2：	1
6	Interleukin-6 regulates prostate-specific protein expression in prostate carcinoma cells by activation of the androgen receptor 显示文摘	HOBISCH A EDER IE PUTZ T	1998	Cancer Res1998，58，20：	1
7	Expression of transforming growth factors beta-l, beta2 and beta3 in human bladder carcinomas 显示文摘	Eder IE Stenzl A Hobisch A	1997	Br J Cancer1997，75，：	1
8	Insulin-like growth factors and insulin control a multifunctional signalling network of significant importance in cancer显示文摘	Massoner P Ladurner-Rennau M Eder IE		0，，10：	1
9	Interleukin-6 regulates pros- tate-specific protein expression in prostate carcinoma cells by acti- vation of the androgen receptor 显示文摘	Hobisch A Eder IE Putz T	1998	Cancer Res1998，58，20：	1
10	Overexpression oF THE ANTI-apoptotic protein MCL-1 IS AN early event in prostate cancer显示文摘	Pfeil K Eder IE Bektic J		0，，2：	1
11	Transforming growth factor-β1 andβ2 in serum and urine from patients with bladder carcinoma显示文摘	Eder IE Stenzl A Hobisch A	1996	J Urol1996，156，3：	1
12	Insulin-likegrowth factors and insulin control a multifunctional signalling net-work of significant importance in cancer显示文摘	Massoner P Ladurner-Rennau M Eder IE	2010	Br J Cancer2010，103，10：	1
13	Inhibition of LNCaP prostate cancer cells by means of androgen receptor antlsense oligonucleotides 显示文摘	Eder IE Culig Z Ramoner R	2000	Cancer Gene Ther2000，7，7：	1
14	Inhibition of LNCaP prostate tumor growth in vivo by an antisense oligonucleotide directed against the human androgen receptor 显示文摘	Eder IE Hoffmann J Rogatsch H	2002	Cancer Gene Ther2002，9，2：	1
15	Overexpression oF THE ANTI-apoptotic protein MCL-1IS AN early event in prostate cancer显示文摘	Pfeil K Eder IE Bektic J	2004	Eu-ropean Urology Supplements2004，3，2：	1
16	Targeting the androgen receptor in hormone refractory prostate cancer-new concepts显示文摘	Eder IE Haag P Bartsch G	2005	Future Oncol2005，1，1：	1
17	Inhibition of LNCaP prostate tumor growth in vivo by an antisense oligonuceotide directed against the human androgen receptor 显示文摘	Eder IE Hoffmann J Rogatsch H	2002	Cancer Gene Ther2002，9，2：	1
18	Inhibition of LNCaP prostate tumor growth in vivo by an antisense ohgonucleotide directed against the human androgen receptor显示文摘	Eder IE Hoffmann J Rogatsch H	2002	Cancer Gene Ther2002，9，2：	1
19	Molecular biology of the androgen receptor:from molecular understanding to the clinic显示文摘	Eder IE Culig Z Putz T	2001	Eur Urol2001，40，：	1
20	Long-term androgen-ablation causes increased resistance to PI3K/AKt pathway inhibition in prostate cancer cells显示文摘	Pfeil K Eder IE Putz T	2004	Prostate2004，58，3：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示